We tested if the RNA expression data of six pathway-related genes and NQO1-IHC might be a reliable alternative using 348 KEAP1/NFE2L2 mutation-enriched NSCLC. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.